Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
84.57 CHF | +0.06% | -1.92% | -0.49% |
12:33am | US FDA mandates label updates on CAR-T cancer therapies | RE |
Apr. 18 | NOVARTIS AG : UBS reiterates its Buy rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.49% | 203B | |
+27.97% | 672B | |
+23.81% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.11% | 211B | |
-10.06% | 194B | |
-11.81% | 144B | |
-8.80% | 141B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- NOVARTIS AG : JP Morgan reiterates its Sell rating